Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
NCT Number: NCT07133412
The goal of this study is to use electromyography-based train-of-four monitoring (TetraGraph™ Neuromuscular Transmission Monitor) as a means of evaluating differences in neuromuscular transmission between infants ≤ 3 months of age and adolescent and older patients (≥ 12 years of age).
Trial opening soon.
Get Notified28 day–25 year
All sexes
Interventional
Not applicable
Columbus, Ohio, 43205, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
TetraGraph is a unique, EMG-based portable device for quantitative (objective) monitoring of neuromuscular function. It is a precise and easy to use tool for monitoring depth of block, ensuring adequate recovery of muscle function, and aiding the clinician to reduce the incidence of residual block.
Time frame: First 30 minutes of surgery
Average amplitude of the evoked response of the muscles.
Trial opening soon.
Get NotifiedJoseph D. Tobias
Other
An Evaluation of the Neuromuscular Junction in Infants Using Train-of-four Monitoring With the TetraGraph™ Neuromuscular Transmission Monitor
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07558694
Surgery
Columbus, Ohio, United States
View Trial DetailsNCT07791485
Bone Diseases, Musculoskeletal Diseases
View Trial DetailsNCT07076641
Digestive System Disease, Digestive System Diseases
Lyon, France
View Trial DetailsNCT07785076
Antimicrobial, Bellwether
View Trial Details